Pharma Bio Serv Stock Price, News & Analysis (OTCMKTS:PBSV)

$0.53 0.00 (0.00 %)
(As of 01/16/2018 04:00 PM ET)
Previous Close$0.53
Today's RangeN/A
52-Week Range$0.32 - $0.87
Average Volume3,405 shs
Market Capitalization$12.13 million
P/E Ratio-8.75
Dividend YieldN/A

About Pharma Bio Serv (OTCMKTS:PBSV)

Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.

Receive PBSV News and Ratings via Email

Sign-up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Management Services
SectorBusiness Services


Debt-to-Equity RatioN/A
Current Ratio14.31%
Quick Ratio14.31%


Trailing P/E Ratio-8.75
Forward P/E Ratio-10.50
P/E GrowthN/A

Sales & Book Value

Annual Sales$19.54 million
Price / Sales0.62
Cash FlowN/A
Price / CashN/A
Book Value$0.95 per share
Price / Book0.55


Trailing EPS($0.06)
Net Income$-250,000.00
Net Margins-8.33%
Return on Equity-6.47%
Return on Assets-6.00%


Outstanding Shares23,100,000

Pharma Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions

What is Pharma Bio Serv's stock symbol?

Pharma Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."

How were Pharma Bio Serv's earnings last quarter?

Pharma Bio Serv Inc (OTCMKTS:PBSV) released its earnings results on Thursday, January, 29th. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.01. The business had revenue of $7.14 million for the quarter, compared to analyst estimates of $7.09 million. Pharma Bio Serv had a negative return on equity of 6.47% and a negative net margin of 8.33%. View Pharma Bio Serv's Earnings History.

When will Pharma Bio Serv make its next earnings announcement?

Pharma Bio Serv is scheduled to release their next quarterly earnings announcement on Tuesday, January, 30th 2018. View Earnings Estimates for Pharma Bio Serv.

Who are some of Pharma Bio Serv's key competitors?

Who are Pharma Bio Serv's key executives?

Pharma Bio Serv's management team includes the folowing people:

  • Elizabeth Plaza, Chairman of the Board (Age 52)
  • Victor Sanchez, President, Chief Executive Officer (Age 44)
  • Pedro J. Lasanta, Chief Financial Officer, Vice President - Finance and Administration, Secretary (Age 55)
  • Howard Spindel, Independent Director (Age 72)
  • Irving L. Wiesen, Independent Director (Age 60)

How do I buy Pharma Bio Serv stock?

Shares of Pharma Bio Serv can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pharma Bio Serv's stock price today?

One share of Pharma Bio Serv stock can currently be purchased for approximately $0.53.

How big of a company is Pharma Bio Serv?

Pharma Bio Serv has a market capitalization of $12.13 million and generates $19.54 million in revenue each year. The company earns $-250,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis. Pharma Bio Serv employs 185 workers across the globe.

How can I contact Pharma Bio Serv?

Pharma Bio Serv's mailing address is Industrial Zone Street 1, Lot 14, DORADO, 00646, Puerto Rico. The company can be reached via phone at +1-787-2782709 or via email at [email protected]

MarketBeat Community Rating for Pharma Bio Serv (PBSV)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  52
MarketBeat's community ratings are surveys of what our community members think about Pharma Bio Serv and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Pharma Bio Serv (OTCMKTS:PBSV) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Pharma Bio Serv (OTCMKTS:PBSV) Earnings History and Estimates Chart

Earnings by Quarter for Pharma Bio Serv (OTCMKTS:PBSV)

Pharma Bio Serv (OTCMKTS PBSV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/14/2017Q3 2017($0.01)($0.01)ViewN/AView Earnings Details
6/14/2017Q2 2017($0.01)($0.01)ViewN/AView Earnings Details
3/17/2017Q1 2017($0.01)($0.02)ViewN/AView Earnings Details
1/31/2017Q4 2016($0.02)ViewN/AView Earnings Details
9/14/2016Q3 2016$0.01($0.01)ViewN/AView Earnings Details
3/16/2016Q1 2016$0.01$0.02ViewN/AView Earnings Details
1/29/2016Q4 2015$0.02ViewN/AView Earnings Details
9/14/2015Q3 2015$0.02$0.02ViewN/AView Earnings Details
6/15/2015Q2 2015$0.02$0.02ViewN/AView Earnings Details
3/17/2015Q1 2015$0.03$0.01ViewN/AView Earnings Details
1/29/2015$0.03$0.04$7.09 million$7.14 millionViewN/AView Earnings Details
9/15/2014$0.02$0.03$7.37 million$6.84 millionViewN/AView Earnings Details
6/16/2014$0.05$0.01$7.51 million$6.58 millionViewN/AView Earnings Details
3/17/2014Q1 2014$0.03ViewN/AView Earnings Details
1/29/2014Q4 2013$0.05ViewN/AView Earnings Details
9/16/2013Q3 2013$0.05$0.05ViewN/AView Earnings Details
6/14/2013Q2 2013$0.06ViewN/AView Earnings Details
3/18/2013Q1 2013$0.05ViewN/AView Earnings Details
1/29/2013Q4 2012$0.05ViewN/AView Earnings Details
9/14/2012Q3 2012$0.06ViewN/AView Earnings Details
6/14/2012Q2 2012$0.05ViewN/AView Earnings Details
3/16/2012Q1 2012$0.05ViewN/AView Earnings Details
1/30/2012Q4 2011$0.04ViewN/AView Earnings Details
9/14/2011Q3 2011$0.07ViewN/AView Earnings Details
6/14/2011Q2 2011$0.02ViewN/AView Earnings Details
3/17/2011Q1 2011$0.02ViewN/AView Earnings Details
1/31/2011Q4 2010$0.01ViewN/AView Earnings Details
9/14/2010Q3 2010$0.01ViewN/AView Earnings Details
1/29/2010Q4 2009$0.01ViewN/AView Earnings Details
6/15/2009Q2 2009$0.01ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Pharma Bio Serv (OTCMKTS:PBSV) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.05 EPS
Next Year EPS Consensus Estimate: $0.02 EPS


Dividend History for Pharma Bio Serv (OTCMKTS:PBSV)

No dividend announcements for this company have been tracked by

Insider Trades

Pharma Bio Serv (OTCMKTS PBSV) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 51.20%
Insider Trades by Quarter for Pharma Bio Serv (OTCMKTS:PBSV)

Pharma Bio Serv (OTCMKTS PBSV) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/11/2014Kirk Wheeler MichelDirectorSell9,170$2.06$18,890.20View SEC Filing  
(Data available from 1/1/2013 forward)


Pharma Bio Serv (OTCMKTS PBSV) News Headlines


SEC Filings

Pharma Bio Serv (OTCMKTS:PBSV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Pharma Bio Serv (OTCMKTS PBSV) Stock Chart for Tuesday, January, 16, 2018

Loading chart…

This page was last updated on 1/16/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.